An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
- DOI
- 10.1002/prp2.845
- Published
- 2021-08-20
- Container
- Pharmacology Research & Perspectives
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/prp2.845,
title = {An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer},
author = {Josephina P. M. Vrouwe and Ingrid M. C. Kamerling and Michiel J. van Esdonk and Josbert M. Metselaar and Frederik E. Stuurman and Gabri van der Pluijm and Jacobus Burggraaf and Susanne Osanto},
year = {2021},
journal = {Pharmacology Research \& Perspectives},
doi = {10.1002/prp2.845},
url = {https://doi.org/10.1002/prp2.845}
}RIS
TY - JOUR TI - An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer AU - Josephina P. M. Vrouwe AU - Ingrid M. C. Kamerling AU - Michiel J. van Esdonk AU - Josbert M. Metselaar AU - Frederik E. Stuurman AU - Gabri van der Pluijm AU - Jacobus Burggraaf AU - Susanne Osanto PY - 2021 JO - Pharmacology Research & Perspectives DO - 10.1002/prp2.845 UR - https://doi.org/10.1002/prp2.845 ER -
APA
Vrouwe, J. P. M., Kamerling, I. M. C., Esdonk, M. J. V., Metselaar, J. M., Stuurman, F. E., Pluijm, G. V. D., Burggraaf, J., & Osanto, S. (2021). An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.845
Source records
- crossref · retrieved 2026-09-27T08:28:13.119Z